BIOCRYST PHARMACEUTICALS INC's ticker is BCRX and the CUSIP is 09058V103. A total of 118 filers reported holding BIOCRYST PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 1.77 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,434,403 | +1.6% | 767,571 | +1.1% | 0.00% | 0.0% |
| Q2 2023 | $5,346,768 | -4.4% | 759,484 | +13.3% | 0.00% | 0.0% |
| Q1 2023 | $5,592,871 | -28.0% | 670,608 | -0.9% | 0.00% | -50.0% |
| Q4 2022 | $7,772,213 | -8.1% | 677,022 | +0.8% | 0.00% | 0.0% |
| Q3 2022 | $8,460,000 | +29.0% | 671,412 | +8.3% | 0.00% | +100.0% |
| Q2 2022 | $6,559,000 | -54.8% | 619,871 | -30.5% | 0.00% | -66.7% |
| Q1 2022 | $14,506,000 | +22.1% | 892,108 | +4.0% | 0.00% | +50.0% |
| Q4 2021 | $11,882,000 | +10.6% | 857,932 | +14.7% | 0.00% | 0.0% |
| Q3 2021 | $10,747,000 | -7.9% | 747,821 | +1.3% | 0.00% | 0.0% |
| Q2 2021 | $11,672,000 | +60.6% | 738,313 | +3.3% | 0.00% | +100.0% |
| Q1 2021 | $7,270,000 | +28.7% | 714,901 | -5.7% | 0.00% | 0.0% |
| Q4 2020 | $5,647,000 | +126.2% | 758,102 | +4.4% | 0.00% | 0.0% |
| Q3 2020 | $2,496,000 | -37.0% | 726,434 | -12.6% | 0.00% | 0.0% |
| Q2 2020 | $3,959,000 | +204.3% | 830,918 | +27.7% | 0.00% | – |
| Q1 2020 | $1,301,000 | -30.7% | 650,638 | +19.6% | 0.00% | – |
| Q4 2019 | $1,876,000 | +50.6% | 543,801 | +25.1% | 0.00% | – |
| Q3 2019 | $1,246,000 | -27.3% | 434,680 | -3.9% | 0.00% | – |
| Q2 2019 | $1,714,000 | -76.7% | 452,282 | -49.9% | 0.00% | -100.0% |
| Q1 2019 | $7,348,000 | +67.6% | 902,660 | +66.2% | 0.00% | +100.0% |
| Q4 2018 | $4,383,000 | +36.5% | 543,026 | +29.0% | 0.00% | 0.0% |
| Q3 2018 | $3,211,000 | +37.2% | 420,825 | +3.1% | 0.00% | 0.0% |
| Q2 2018 | $2,340,000 | +6.1% | 408,281 | -11.7% | 0.00% | 0.0% |
| Q1 2018 | $2,205,000 | -3.2% | 462,370 | -0.4% | 0.00% | 0.0% |
| Q4 2017 | $2,279,000 | +17.5% | 464,191 | +25.4% | 0.00% | 0.0% |
| Q3 2017 | $1,939,000 | -5.6% | 370,031 | +0.1% | 0.00% | 0.0% |
| Q2 2017 | $2,055,000 | -32.3% | 369,561 | +2.3% | 0.00% | 0.0% |
| Q1 2017 | $3,035,000 | +41.8% | 361,289 | +6.8% | 0.00% | 0.0% |
| Q4 2016 | $2,141,000 | +52.3% | 338,217 | +6.1% | 0.00% | – |
| Q3 2016 | $1,406,000 | +61.6% | 318,879 | +4.0% | 0.00% | – |
| Q2 2016 | $870,000 | +0.1% | 306,563 | -0.2% | 0.00% | – |
| Q1 2016 | $869,000 | -74.1% | 307,115 | -5.5% | 0.00% | -100.0% |
| Q4 2015 | $3,355,000 | -11.0% | 325,140 | -1.6% | 0.00% | 0.0% |
| Q3 2015 | $3,768,000 | -35.6% | 330,543 | -15.7% | 0.00% | -50.0% |
| Q2 2015 | $5,851,000 | +77.1% | 391,890 | +7.1% | 0.00% | +100.0% |
| Q1 2015 | $3,304,000 | -25.8% | 365,964 | -0.1% | 0.00% | 0.0% |
| Q4 2014 | $4,454,000 | +27.5% | 366,332 | +2.6% | 0.00% | 0.0% |
| Q3 2014 | $3,494,000 | -57.8% | 357,210 | -45.0% | 0.00% | 0.0% |
| Q2 2014 | $8,280,000 | +758.9% | 649,430 | +612.6% | 0.00% | – |
| Q1 2014 | $964,000 | +11.8% | 91,135 | -19.6% | 0.00% | – |
| Q4 2013 | $862,000 | -50.9% | 113,371 | -53.0% | 0.00% | – |
| Q3 2013 | $1,756,000 | +1240.5% | 241,432 | +186.8% | 0.00% | – |
| Q2 2013 | $131,000 | – | 84,193 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management, LLC | 1,744,356 | $18,455,000 | 9.59% |
| RA Capital Management | 4,347,456 | $45,996,000 | 3.30% |
| Cormorant Asset Management, LP | 1,168,000 | $12,357,000 | 2.84% |
| Baker Brothers Advisors | 5,867,031 | $62,073,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 907,920 | $9,606,000 | 0.39% |
| QVT Financial LP | 525,734 | $5,562,000 | 0.32% |
| EAM Investors, LLC | 114,548 | $1,212,000 | 0.22% |
| FRANKLIN STREET ADVISORS INC /NC | 93,000 | $984,000 | 0.20% |
| THB ASSET MANAGEMENT | 301,529 | $3,190,000 | 0.19% |
| TPG Group Holdings (SBS) Advisors, Inc. | 1,162,269 | $12,297,000 | 0.13% |